HER 2 Negative Breast Cancer Completed Phase 2 Trials for Albumin human (DB00062)

Also known as: HER2- Negative Breast Cancer / HER2-Negative Breast Cancer / HER2 Negative Breast Cancer / HER-2 Negative Breast Cancer

IndicationStatusPhase
DBCOND0107236 (HER 2 Negative Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00733408Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast CancerTreatment